Home - Products - Others - Other Targets - [Tyr0]-Prepro-Atrial Natriuretic Factor (104-123) (human)

[Tyr0]-Prepro-Atrial Natriuretic Factor (104-123) (human)

CAS No. 309245-24-7

[Tyr0]-Prepro-Atrial Natriuretic Factor (104-123) (human)( ——— )

Catalog No. M41418 CAS No. 309245-24-7

[Tyr0]-Prepro-Atrial Natriuretic Factor (104-123) (human)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    [Tyr0]-Prepro-Atrial Natriuretic Factor (104-123) (human)
  • Note
    Research use only, not for human use.
  • Brief Description
    [Tyr0]-Prepro-Atrial Natriuretic Factor (104-123) (human)
  • Description
    [Tyr0]-Prepro-Atrial Natriuretic Factor (104-123) (human)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    309245-24-7
  • Formula Weight
    2346.8
  • Molecular Formula
    C103H180N32O30
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • C-Reactive Protein (...

    CRP, an acute phase serum protein synthesized in response to inflammatory cytokines, produces antitumor effects in animals. The fragment CRP (174-185) (RS-83277) shows similar activity by significantly enhancing the tumoricidal activity of human monocytes and alveolar macrophages in vitro.

  • DL-Tryptophan

    Tryptophan containing dipeptides are interesting ingredients for functional foods as a natural prevention for hypertension with reduced side effects due to its selective inhibition of the C-domain.

  • CGS 20625

    CGS 20625 is an orally active, specific, and potent partial agonist at the central benzodiazepine receptor with anxiolytic and anticonvulsant activity.